989 Acquired Resistance to Aromatase Inhibitors is Paired With Hyper-activation of Akt/mTor Pathway in New Cellular Models of Hormone-dependent Breast Cancer
Paul Vilquin(Université Claude Bernard Lyon 1), Pascale A. Cohen(Lyon 1 Université), Sandra E. Ghayad(Inserm), Isabelle Treilleux(Centre Léon Bérard), Laura Corbo(Centre National de la Recherche Scientifique), J.A. Vendrell(Centre National de la Recherche Scientifique), Thomas Bachelot(Centre Léon Bérard), Marie Villedieu(Cancers et Préventions), Sabrina Ben Larbi(Lyon 1 Université), Evelyne Grisard(Lyon 1 Université)
Cited by 0
Related Papers
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2023|830
Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial
|Journal of Clinical Oncology|2020|556
Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)
|The Lancet Oncology|2014|410
SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas
|Nature Genetics|2015|375
Cracking the Estrogen Receptor's Posttranslational Code in Breast Tumors
|Endocrine Reviews|2011|302